Replies to post #199962 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

That could explain the increase from 86 to over 90%.

[Doc logic]

Lykiri,

Were SOC patients crossed over to treatment on the down low and reported as lost to followup to maintain the blind? I have not looked at where the LTFs came from again before this post time wise but 11 on SOC in 2017 instead of sentiment_stocks recent conservative figure in the low 20s might fit better with the lowered inclusion standards and otherwise perhaps rapid SOC/placebo eventing. NWBO has not shared 2015 or 2016 Spring Refresh data. I wonder if we might have a good guess why now with over 90% having received treatment. Seems like 86+% in 2017 jumping to over 90% in 2018 might be an "accounting" correction. Best wishes.